Volume 43, Issue 3, Pages (September 2015)

Slides:



Advertisements
Similar presentations
Viral and Cellular Genomes Activate Distinct DNA Damage Responses
Advertisements

Kenneth I. Aston, Ph. D. , Philip J. Uren, Ph. D. , Timothy G
Volume 138, Issue 2, Pages (July 2009)
Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Volume 24, Issue 3, Pages (March 2006)
Bridget A. Robinson, Timothy J. Nice  Immunity 
Volume 98, Issue 4, Pages (February 2010)
Volume 11, Issue 11, Pages (June 2015)
Jennifer R. Hamilton, Gayathri Vijayakumar, Peter Palese  Cell Reports 
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Sterol-izing Innate Immunity
NMD: Nonsense-Mediated Defense
Volume 33, Issue 1, Pages (July 2010)
Volume 12, Issue 4, Pages (October 2012)
Kenneth I. Aston, Ph. D. , Philip J. Uren, Ph. D. , Timothy G
Volume 54, Issue 1, Pages (April 2014)
Strength in Numbers: Visualizing CTL-Mediated Killing In Vivo
Volume 20, Issue 12, Pages (September 2017)
PU.1 Takes Control of the Dendritic Cell Lineage
Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity  Kenichi.
Volume 35, Issue 3, Pages (September 2011)
Walking the Interactome for Prioritization of Candidate Disease Genes
Translation of Genotype to Phenotype by a Hierarchy of Cell Subsystems
Volume 20, Issue 7, Pages (August 2017)
Recurrence-Associated Long Non-coding RNA Signature for Determining the Risk of Recurrence in Patients with Colon Cancer  Meng Zhou, Long Hu, Zicheng.
Volume 4, Issue 3, Pages (August 2013)
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Volume 20, Issue 5, Pages e7 (May 2017)
Systematic Analysis of Tissue-Restricted miRISCs Reveals a Broad Role for MicroRNAs in Suppressing Basal Activity of the C. elegans Pathogen Response 
Volume 33, Issue 1, Pages (July 2010)
Volume 36, Issue 4, Pages (April 2012)
Volume 24, Issue 11, Pages e3 (September 2018)
Volume 43, Issue 6, Pages (December 2015)
Volume 20, Issue 12, Pages (September 2017)
Volume 21, Issue 6, Pages (November 2017)
Volume 49, Issue 2, Pages (January 2013)
Predicting drug sensitivity and resistance
Volume 35, Issue 3, Pages (September 2011)
Volume 6, Issue 6, Pages (March 2014)
Boosting Signal-to-Noise in Complex Biology: Prior Knowledge Is Power
Molecular Therapy - Nucleic Acids
Volume 37, Issue 6, Pages (December 2012)
Volume 135, Issue 1, Pages (October 2008)
Volume 35, Issue 2, Pages (August 2011)
Volume 5, Issue 2, Pages e4 (August 2017)
Volume 22, Issue 2, Pages (February 2005)
Mesenchymal Stem Cell Features of Ewing Tumors
Volume 11, Issue 11, Pages (June 2015)
Volume 18, Issue 6, Pages (December 2015)
Volume 35, Issue 4, Pages (October 2011)
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 138, Issue 2, Pages (July 2009)
Volume 67, Issue 6, Pages e9 (September 2017)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 5, Issue 6, Pages (December 2013)
Volume 30, Issue 4, Pages (April 2009)
Volume 55, Issue 6, Pages (September 2014)
Volume 39, Issue 3, Pages (August 2010)
Volume 40, Issue 2, Pages (February 2014)
Volume 35, Issue 4, Pages (October 2011)
Volume 16, Issue 11, Pages (September 2016)
Volume 24, Issue 3, Pages (March 2006)
Volume 11, Issue 10, Pages (June 2015)
Volume 2, Issue 3, Pages (March 2016)
Hyunghoon Cho, Bonnie Berger, Jian Peng  Cell Systems 
Volume 4, Issue 2, Pages e4 (February 2017)
Generation of an HPV–human PPI map.
Peter Palese, Terrence M. Tumpey, Adolfo Garcia-Sastre  Immunity 
Volume 3, Issue 6, Pages e3 (December 2016)
Presentation transcript:

Volume 43, Issue 3, Pages 605-614 (September 2015) Interactive Big Data Resource to Elucidate Human Immune Pathways and Diseases  Dmitriy Gorenshteyn, Elena Zaslavsky, Miguel Fribourg, Christopher Y. Park, Aaron K. Wong, Alicja Tadych, Boris M. Hartmann, Randy A. Albrecht, Adolfo García-Sastre, Steven H. Kleinstein, Olga G. Troyanskaya, Stuart C. Sealfon  Immunity  Volume 43, Issue 3, Pages 605-614 (September 2015) DOI: 10.1016/j.immuni.2015.08.014 Copyright © 2015 Elsevier Inc. Terms and Conditions

Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 ImmuNet Development and Selected Applications Data from more than 38,000 experiments (including mRNA expression, protein interaction assays, and phenotypic assays) were collected from public repositories and systematically processed (see Supplemental Computational Methods). These data and curated immune pathway prior knowledge from KEGG were used as input to infer 15 immune-specific functional relationship networks and an overall Immune Global context averaged network. Each immune-specific functional network predicts functional association between molecular entities (genes or proteins) specific to a particular immune biological process (e.g., antigen processing and presentation). ImmuNet leverages this massive data compendium to predict novel immune process or immune disease associations. See Supplemental Computational Methods for full information on the data compendium and integration. Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 ImmuNet Accurately Recapitulates Known Functional Relationships in Immune Pathways (A) ImmuNet networks were evaluated via 3-fold cross-validation. For each pathway, one-third of the pathway data was iteratively omitted when constructing the network and the accuracy of this network in predicting the held-out information was tested. The panel shows the successful recovery of held-out immune data when we used the standard area-under receiver operator curve (AUC) metric that reflects both specificity and sensitivity (Hastie et al., 2011). Bar plots represent the mean ± SEM of the three cross-validations. (B) Using 3-fold cross-validation, the performance of the ImmuNet global network was compared to two standard non-immune-specific networks, BioGRID PPI network and a functional integration Human Global network. Boxplots represent the AUC performance distribution of each network at recovering known immune relationships (from the 15 KEGG contexts) that were held out during the training of each network. ImmuNet significantly outperformed the other two networks. p values are based on Wilcoxon signed-rank test. See also Figure S1 and Table S1. Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Illustration of the Use of Immune-Specific Functional Networks (A) High-confidence subnetwork obtained by querying the ImmuNet hematopoietic cell lineage network with IFNAR1 (Interferon receptor 1) and FAS (Cell surface death receptor). The subnetwork obtained predicted that the processes reflected by the query genes are functionally related to PTGER2 and MNDA. The visualization parameters used to generate the graph shown are minimum relationship confidence = 0.61 and maximum number of genes = 21. (B) The relationship of MNDA to cell death in the context of antiviral responses was evaluated by comparing its induction by infection of DCs by IAV that induce cell death (seasonal viruses NC/99; TX/91) or do not induce cell death (pandemic viruses Brevig, Cal/09) in these cells. Data shown is 8 hr after infection at MOI = 1, normalized to the levels obtained with vehicle-treated cells. Notably, MNDA is differentially induced by the two virus groups. Bar plots represent the mean ± SEM gene expression fold-change of three replicate infections. See also Table S2. Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Functional Networks Predict Specificity of Influenza Viral Infection (A) Pathogenic viruses, such as the NC/99 IAV strain, have developed immune antagonist mechanisms to suppress components of the antiviral response gene program. Genes induced in human DCs infected with NC/99 (Zaslavsky et al., 2013) were used as input for an ImmuNet-based method to predict differential absence genes. With these 183 genes as positive examples, an SVM classifier was trained to identify genes in the Immune Global network that were closely related to the seed set but were not induced by NC/99. The absence of these “expected” genes identified them as candidates for NC/99 immune antagonist mechanisms. (B) DCs were infected at MOI = 1 with NC/99 or NDV. Infectivity was assayed by immunostaining of viral proteins (NP for NC/99 and HN for NDV). Antiviral gene MX1 was induced by each virus, assayed by RT-PCR, indicating virus detection and initiation of cellular responses. (C) Expression levels of the 16 SVM-classifier top-ranked “expected” absence genes 8 hr after NC/99 or NDV infection were assayed. Seven of the predicted genes were significantly higher after NDV infection at 8 hr (p < 0.05). Data represent mean ± SEM from three independent experiments, each performed in triplicate. Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Immune-Specific Functional Networks Accurately Predict Gene-Disease Associations To predict disease-associated genes, SVM classifiers were trained using ImmuNet with OMIM genes annotated to CVID, IBD, and RA. (A) Results of 3-fold cross-validation, in which each classifier was trained without one-third of the known positives, and the accuracy of predicting this held-out information was evaluated by receiver-operator AUC. (B) Prediction of GWAS-associated genes by ImmuNet classifiers. The relationships of the SVM classifier score and reported GWAS-associated genes were determined. The graph shows differences in the probability density of genes reported as GWAS associated in comparison with other genes in the network. Genes with high SVM scores were highly significantly enriched in reported GWAS-associated genes for all three diseases. (C) Prediction of reported IBD eQTL genes by ImmuNet IBD classifier. The relationship of the SVM classifier scores and reported eQTL genes was determined. The graph shows a significant difference in the probability density of genes identified by eQTL analysis in comparison with other genes in the network. See also Figure S2 and Table S3. Immunity 2015 43, 605-614DOI: (10.1016/j.immuni.2015.08.014) Copyright © 2015 Elsevier Inc. Terms and Conditions